Cell Wall Inhibiting Antibiotics Flashcards
Steps of cell wall synthesis
1) synthesis and assembly of cell wall subunits in cytosol
2) linear polymerization of subunits @ membrane
3) cross-linking of peptidoglycans
Penicillin mechanism of action
Beta lactam. Irreversibly inhibits cross-linking (3) by acetylating penicillin binding proteins (PBPs) including transpeptidases. Also trigger autolytic enzymes by depressing the inhibitory action of autolysins. Leads to post-antibiotic effect.
pen resistance
1) plasmid-mediated penicillinase production (as in MSSA)
2) alteration in PBPs (MRSA)
3) drug unable to penetrate (can’t enter many G- [pseudomonas] due to outer mmbr)
4) “escape”– metabolically inactive organisms can evade
pen administration
Strongish acids. Pen G oral dose must be high, taken on empty stomach.
Pen V and amoxicillin have modified R-group to improve acid stability
Piperacillin- IV only
Abs throughout body water. Penetrates cells/tissues poorly, but can enter inflamed tissues (csf, joints, eye)
Insoluble salts reduce abs and extend duration
Pen excretion
90% renal tubular excretion
PenG/V
G: hydrolyzed by acid and enzymes. used IV for serious infections
V: acid resistant. Better oral abs for mild-mod abs
penicillinase-resistant
dicloxacillin, nafcillin. eliminated by renal and hepatic routes, improving safety in renal insufficiency. less potent than pen G
extended spectrum pens
increased hydrophilicity, allowing passage through porins. on outer membrane of G- bacteria.
Ampicillin plus/minus sublactam, Amoxacillin plus/minus clavulanic acid (B-lactamase inhibitors)
Anti-pseudomonal pen
Piperacillin plus tazobactam
Vancomycin
Discovered in Borneo.
Inhibits linear polymerization of PGs (step 2). IV administration. Renal excretion, so half life extended in renal failure.
Use against:
G+ cocci–MRSA, staph/streo, ampicillin resistant enterococci
anaerobes: C. diff
Cephalosporins
broader G- activity compared to Pen
less susceptible to penicillinases
1st gen. Cephs
Cefazolin, cephalexin. G+ cocci, G- bacilli (similar to amoxicillin)
2nd gen. Cephs
Cefuroxine: G+, better than gen 1 at G-
active against anaerobes (B. fragilis)
3rd gen. Cephs
Cefdinir, Ceftriaxone, Ceftazidine: Expanded G- coverage against enteric bacilli
4th gen. Cephs
Cefepime: Similar to 3rd gen, more resistant to B-lactamases. Effective against Pseudomonas